港股異動 | 三葉草生物(2197.HK)高開超5% 新冠候選疫苗獲得歐盟GMP認證

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

港股異動 | 三葉草生物(2197.HK)高開超5% 新冠候選疫苗獲得歐盟GMP認證

格隆匯 09-21 09:23

格隆匯9月21日丨三葉草生物(2197.HK)高開超5%，報2.72港元，總市值31億港元。該公司昨日盤後宣佈，公司的合同開發生產商已經獲得歐盟藥品生產質量管理規範("歐盟GMP")認證，用於生產三葉草生物主要的新冠候選疫苗SCB-2019(CpG1018╱鋁佐劑)，標誌着SCB-2019(CpG1018╱鋁佐劑)的生產符合歐盟的質量和安全標準。

三葉草生物-B(02197.HK)

Relevant Stocks

三葉草生物-B(02197.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

港股異動 | 三葉草生物(2197.HK)高開超5% 新冠候選疫苗獲得歐盟GMP認證

Services

About Us

Agreement Statement